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ABSTRACT 
The Bunyavirales order of segmented 
negative-sense RNA viruses includes > 500 
isolates that infect insects, animals, and 
plants and are often associated with severe 
and fatal disease in humans. To multiply 
and cause disease, bunyaviruses must 
translocate their genomes from outside the 
cell into the cytosol, achieved by transit 
through the endocytic network. We have 
previously shown that the model 
bunyaviruses Bunyamwera virus (BUNV) 
and Hazara virus (HAZV) exploit the 
changing potassium concentration ([K+]) of 
maturing endosomes to release their 
genomes at the appropriate endosomal 
location. K+ was identified as a biochemical 
cue to activate the viral fusion machinery, 
promoting fusion between viral and cellular 
membranes, consequently permitting 
genome release. In this study, we further 
define the biochemical prerequisites for 
BUNV and HAZV entry and their K+ 
dependence. Using drug±mediated 
cholesterol extraction along with viral-
entry and K+ uptake assays, we report three 
major findings: (1) BUNV and HAZV 
require cellular cholesterol during 
endosomal escape; (2) cholesterol depletion 
from host cells impairs K+ accumulation in 
maturing endosomes, revealing new 
insights into endosomal K+ homeostasis; 
and (3) ³SULPLQJ´ BUNV and HAZV 
virions with K+ before infection alleviates 
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their cholesterol requirement. Taken 
together, our findings suggest a model in 
which cholesterol abundance influences 
endosomal K+ levels and consequently the 
efficiency of bunyavirus infection. The 
ability to inhibit bunyaviruses with existing 
cholesterol-lowering drugs may offer new 
options for future antiviral interventions for 
pathogenic bunyaviruses.  
Word count: 231  
 
 
 
INTRODUCTION 
 The order Bunyavirales represents 
the largest taxonomic collection of single-
stranded, negative-sense RNA (-ssRNA) 
viruses, with over 500 named isolates, 
classified into 10 families and 35 genera 
(1). Bunyaviruses infect a wide range of 
hosts including animals, plants, insects and 
humans. Those viruses able to infect 
humans are classified into just four of the 
bunyavirales families, namely 
Hantaviridae, Phenuiviridae, Nairoviridae 
and Peribunyaviridae, with selected species 
able to cause potentially fatal haemorrhagic 
fever or encephalitis in their human hosts 
(2). 
 The genome of all bunyaviruses 
comprises three linear RNA segments that 
are named according to their relative size, 
with the large (L) segment encoding the 
viral RdRp, the medium (M) segment 
encoding envelope-associated 
glycoproteins (Gn and Gc) and the small (S) 
segment encoding the nucleoprotein (N), 
which encapsidates the RNA segments to 
form ribonucleoprotein complexes (RNPs). 
In many bunyavirus species, an additional 
non-structural protein (NSs) is expressed 
from the S segment either from an 
overlapping open reading frame on the N 
mRNA, or alternatively via the generation 
of a discrete mRNA through ambi-sense 
transcription (3). Many bunyaviruses also 
express a non-structural protein from the M 
segment (NSm) which is cleaved from the 
single polyprotein precursor transcribed 
from the single M segment mRNA (4±6). 
 For bunyaviruses to establish 
infection, they must penetrate host cells and 
traverse the endocytic network, prior to 
escape of viral RNPs into the cytosol and 
subsequent gene expression. Cell 
penetration of bunyaviruses occurs through 
attachment of the virus to the cell, followed 
by internalisation through a range of 
mechanisms. It is known that viruses of the 
families Hantaviridae, Nairoviridae and 
Peribunyaviridae are endocytosed through 
a clathrin-dependent mechanism, with 
functional roles for caveolar endocytosis 
and macropinocytosis also described. 
Conversely, viruses of the Phenuiviridae 
enter cells independently of clathrin (7±10). 
Once inside endosomes, bunyaviruses must 
facilitate the escape of their RNPs into the 
cytosol, a process involving the fusion of 
the virus envelope with the endosomal 
membrane. This fusion event is mediated 
by the heteromultimeric glycoprotein 
spikes comprising Gn and Gc, arranged on 
the surface of mature virions in a variety of 
different architectures (11±14). For the 
fusion machinery to be activated, the 
glycoprotein spikes must be subjected to a 
variety of specific biochemical events that 
can occur before or after their inclusion in 
the virion. For instance, most class I and II 
fusion proteins studied to date require a 
proteolytic cleavage event to become fusion 
competent (15). This event is termed 
µSULPLQJ¶ DIWHUZKLFKDYDULHW\RI IXUWKHU
events known as µtriggers¶ induce structural 
changes in the fusion proteins resulting in a 
transition between pre- and post-fusion 
conformations. While the priming step 
involves proteolysis, there is a greater 
variety of triggers including pH and the 
interaction with an internal or external 
cellular receptor. These triggering events 
ensure that fusion between viral and 
cellular membranes is restricted only to an 
appropriate cellular location that leads to 
productive infection (15).  
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 Recently, we used the prototypic 
bunyavirus, Bunyamwera virus (BUNV), 
and the model nairovirus Hazara virus 
(HAZV) to reveal that bunyavirus fusion is 
dependent upon specific changes in both 
pH and ion balance (16, 17). Specifically, 
we identified K+ as a critical biochemical 
trigger required for spike conformational 
changes and interaction with membranes, 
consistent with activation of the fusogenic 
machinery. While this work documented 
how bunyavirus glycoproteins respond to 
specific endosomal conditions, it is likely 
that efficient fusion between virus and 
endosomal membranes requires further 
biochemical requirements as pre-requisites 
for virus entry. In this regard, it is known 
that the composition of biological 
membranes is crucial to the physiological 
function of cells, and cholesterol is an 
important regulator of membrane integrity 
and fluidity, making up 25-50% of the total 
lipid content of animal cells (18). 
Aberrations in cholesterol homeostasis can 
disrupt cellular uptake mechanisms, which 
is important from the view of enveloped 
viruses. The correct composition of 
biological membranes in terms of 
cholesterol has been shown to be important 
to the life cycle of several enveloped 
viruses, in a variety of lifecycle stages 
ranging from entry to release. As well as the 
correct environmental pH, the Togaviridae 
family member Semliki Forest virus (SFV), 
requires high cholesterol composition in 
target membranes for stable insertion of its 
fusion loop (19), whilst the hantavirus 
Andes virus (ANDV) has been 
demonstrated to require high cholesterol in 
target membranes for productive infection 
(20). Cholesterol concentrations also 
influence the hemifusion stage of influenza 
virus (IAV) fusion (21). Aside from the 
entry stages of viral life cycles, cholesterol 
has been shown to be important in the 
assembly and release of mature IAV virions 
which require cholesterol to stabilise 
virions prior to release (22). 
 In this study, we examined how the 
biochemical composition of both host and 
viral membranes influences the crucial 
fusion step in the bunyavirus life cycle. 
Herein, we reveal new insights into the role 
of cholesterol during virion endocytic 
trafficking and endosomal K+ 
accumulation.
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RESULTS 
BUNV infection is inhibited by cellular 
cholesterol depletion 
 Given that enveloped viruses must 
fuse their outer membranes with host 
membranes to cause infection (23), we first 
examined if cholesterol, a key regulator of 
membrane fluidity (24), has a role in this 
process. Cholesterol-rich microdomains 
within the plasma membrane are important 
for the lifecycle of a range of enveloped 
viruses, but their role during the bunyavirus 
lifecycle is poorly characterised.  
 In the following experiments, 
cellular cholesterol was extracted from the 
plasma membrane of BUNV-susceptible 
A549 cells using methyl-beta cyclodextrin 
0ȕ&' and its influence on BUNV 
infection assessed (Fig 1). Cells were 
WUHDWHG ZLWK 0ȕ&' IRU  PLQXWHV to 
sequester cellular cholesterol, and 
incubated with BUNV (MOI = 0.2) for 2 h 
to permit virus penetration. Non-
internalised viruses were removed 2 hrs 
post-infection (hpi) through trypsin 
washing, and the ability of BUNV to 
establish an infection after 24 hrs was 
assessed through the detection of BUNV-N 
by immunofluorescence staining (Fig 1A 
and B). Quantification of cells positive for 
BUNV-N revealed significantly reduced 
OHYHOV RI LQIHFWLRQ XSRQ 0ȕ&' WUHDWPHQW
(reduction to ~29%) (Fig 1B, black bars). 
When BUNV infection was assessed at 
varying concentUDWLRQV RI 0ȕ&' -2 
mM) by western blotting (Fig 1C and D), N 
expression was barely detectable at 0.5-1 
mM, and completely undetectable at 2 mM 
0ȕ&')LJ&UHYHDOLQJDFRQFHQWUDWLRQ
dependent decrease (Fig 1D, black bars). 
Importantly, 0ȕ&' WUHDWPHQW was non-
cytotoxic, evidenced through MTS assays 
(Fig 1B and 1D, grey bars) and the 
equivalent levels of GAPDH in the 
corresponding protein lysates (Fig 1C).  
 To confirm the BUNV cholesterol 
requirement, the effects of PF-429242 
(S1P/SKI-1 inhibitor) (25), and U-18666A 
(lysosomal cholesterol export inhibitor) 
(26) that reduce cellular cholesterol through 
the inhibition of its production and 
trafficking respectively, were assessed (Fig 
1E-H). Both PF-429242 and siRNA-
mediated S1P inhibition have been shown 
to inhibit Andes virus (ANDV) (27), whilst 
U-18666A has inhibitory effects on a 
number of important enveloped viruses, 
including dengue virus (DENV), 
chikungunya virus (CHIKV) and Ebola 
virus (EBOV) (28±30). For these 
experiments, cells were pre-treated with 
PF-429242 for 24 hours (31) and infected 
with BUNV (MOI 0.2, 24 h). Ammonium 
chloride (NH4Cl), a known inhibitor of 
BUNV fusion was included in these assays 
as a positive control (16). PF-429242 at 20 
ȝ0resulted in almost complete abrogation 
of BUNV-N production, whilst 5- ȝ0 
led to drastically reduced BUNV-N 
expression (Fig 1E). Quantification 
revealed that the BUNV-N levels decreased 
to 7.91%, 17.54% and 37.94% in 20, 10 and 
5 ȝ0 drug-treated cells respectively, 
compared to the no-drug control (Fig 1F; 
black bars). MTS assays revealed no 
detrimental effects of PF-429242 on cell 
viability (Fig 1F, grey bars).  
For further confirmation, cells were 
treated with U-18666A under identical 
conditions (26). Fig 1G shows a strong 
inhibition of BUNV in cells treated with 5-
10 ȝ0 8-18666A and more modest 
inhibition at 2.5 ȝ0 8-18666A. Upon 
quantification (Fig 1H, black bars), BUNV-
N expression was reduced to 8.52%, 
22.83% and 42.66% by 10, 5 and 2.5 ȝ0
U18666A, respectively. MTS assays 
confirmed no loss of viability at the 
U18666A concentrations assessed (Fig 1H, 
grey bars).  
Finally, we assessed cholesterol 
depletion as a viable anti-BUNV strategy 
through assessment of the inhibitory effects 
of the clinically approved cholesterol 
lowering drug simvastatin. Fig 1I-J shows 
that BUNV-N expression was reduced by 
50, 35, 20 and 10 ȝM simvastatin treatment 
to 24.74%, 34.29%, 38.82%  and 48.37% 
respectively, when normalised to no-drug 
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controls. MTS assays confirmed no drug 
induced cytotoxicity (Fig 1J, grey bars).  
Taken together, these data obtained via four 
independent methods strongly suggest that 
cholesterol is important during the BUNV 
lifecycle and that clinically-approved 
cholesterol-lowering drugs hold promise as 
a clinically available antiviral strategy.  
 
Both virion envelope and cellular 
cholesterol influence BUNV infection  
As BUNV is an enveloped virus, we 
next assessed whether envelope cholesterol 
contributed to the effects of cholesterol 
lowering compounds. To assess this, we 
used a recombinant BUNV containing GFP 
inserted at the N-terminus of a truncated Gc 
glycoprotein (GFP-Gc) with the deleted 
sequence shown to be dispensable for virus 
infection in cell culture (32, 33). GFP-
BUNV virions were treated in vitro with 
0ȕ&D for 90 minutes at 37°C to sequester 
cholesterol from the virion membrane (Fig 
2A). To mitigate the effects RI 0ȕ&' RQ
the cells, virions were diluted in media prior 
to infection (MOI 0.5, 24 hrs). This ensured 
that any effects of cholesterol depletion 
were mediated by direct effects on the 
virions as opposed to cellular effects.  
From these experiments, we 
observed a ~24% decrease in total BUNV-
N expression following direct 0ȕ&'virion 
treatment (Fig 2B-C) by western blot 
analysis. Upon the assessment of GFP-Gc 
fluorescence (34) (Fig 2D), a larger ~60% 
decrease in the number of infected cells was 
observed (Fig 2E). This confirmed that 
0ȕ&' YLULRQ treatment decreased the 
number of infected cells. The ultrastructure 
of BUNV virions was unaffected by 
cholesterol depletion as negative staining 
showed no gross structural defects in the 
virions following 0ȕ&' treatment (Fig 
2F). We therefore reasoned that BUNV 
infection is dependent on virion as well as 
cellular associated cholesterol. 
 
Cellular cholesterol depletion influences 
BUNV endocytic escape but not cell 
penetration 
To further dissect the role of 
cholesterol during BUNV infection and 
identify the steps at which 0ȕ&'-mediated 
cholesterol extraction inhibits the virus 
lifecycle, time of addition assays were 
performed. We included NH4Cl, an 
endosomal acidification inhibitor, as a 
control which inhibits BUNV at early 
stages of infection, i.e. only during its 
movement through the endocytic system 
(16). Cells were infected with BUNV (MOI 
0.2) (t=0) and NH4&ORU0ȕ&'ZHUHDGGHG
to cells at defined time points up to and 
including 10 hpi. Infection was then 
allowed to proceed until 24 hpi and BUNV-
N expression assessed (Fig 3A-B). Figs 3A 
and C show that BUNV escapes from 
endosomes at or before 6 hpi, as NH4Cl 
treatment did not influence BUNV-N 
production when added 6 hpi, consistent 
with our previous findings (16). 
Interestingly, BUNV sensitivity to 0ȕ&'
followed a similar timecourse (loss of 
inhibition from 6-8 hpi, Fig 3B-C) 
VXJJHVWLQJWKDW0ȕ&'DOVRLQKLELWV%819
early stages of infection. Next, using tris(2-
carboxyethyl)phosphine (TCEP) to 
distinguish between internalized and 
surface-bound particles, we assessed the 
kinetics of BUNV cell penetration. TCEP is 
a membrane-impermeable reducing agent, 
that unactivates BUNV still exposed 
extraceullarly or at the plasma membrane. 
In samples treated with TCEP before 
warming, we observed a loss of TCEP 
inhibition after 40 mins of virus addition as 
assessed by immunofluorescence (Fig. 4D-
E) and western blot analysis (Fig. F). 
Taking into account the NH4Cl effects on 
BUNV, we could confirm that BUNV is 
resident in the endosomal system from 40 
min to 6 hrs post-infection. Importantly, an  
effect of cholesterol depletion on BUNV 
penetration was discounted as we observed 
fluorescently-labelled BUNV (BUNV-
DiDvbt/SYTO82) in which the viral 
envelope was labelled with DiDvbt and its 
RNA genome labelled with SYTO82 in 
distinct endosomal puncta in cells treated 
with 0ȕ&', suggesting that BUNV can 
 5 
 
penetrate cells depleted of cholesterol (Fig 
3D-E). These data suggest that the critical 
role of cholesterol in the BUNV lifecycle 
occurs at a post-penetration 
min)/endocytic stage KUVin agreement 
with that observed for other enveloped 
viruses (35). 
  
Cholesterol extraction reduces K+  
accumulation in endosomes 
 We recently demonstrated that an 
increasing K+ gradient is required to induce 
a fusogenic state in BUNV and HAZV as 
they traffic through the endocytic network 
(16, 36), with high [K+] acting as a 
biochemical cue for priming/activation of 
the fusion glycoproteins Gn/Gc (17). 
Blocking K+ influx into endosomes was 
shown to trap virions in the endocytic 
system, after which they accumulated in 
lysosomes for subsequent degradation. 
 Based on this knowledge, and our 
observation that cholesterol depletion 
influences BUNV at the stage of endosomal 
trafficking, we explored whether 
cholesterol depletion also influences 
endosomal K+ accumulation. To test this, 
we used the K+-sensitive membrane 
impermeable fluorescent dye Asante-K+ 
green 4 (AG4) that specifically labels 
endosomal K+. Endosomes rich in K+ could 
be observed within cells in which the 
intensity of the AG4 signal indicates the 
degree of K+ accumulation (Fig 4A-B). 
When cells ZHUHWUHDWHGZLWK0ȕ&'IRU
minutes and AG4 added, the number of 
AG4 puncta was reduced compared to µQR-
GUXJ¶ treated cells (Fig 4A-B), suggesting 
that cholesterol depletion reduces the 
number of K+-rich endosomes. Alexa-fluor-
594©-conjugated transferrin (TF-594) was 
used as a control in these experiments to 
GHPRQVWUDWHQRLQWHUIHUHQFHRI0ȕ&'ZLWK
general fluorescence or cellular uptake 
pathways (Fig 4A and 4C). Interestingly, 
we found that the intensity of TF-594 
increased in 0ȕ&'-treated cells (2-fold 
increase) which may be attributed to a shift 
between recycling and degradation 
pathways following cholesterol depletion. 
The above data were confirmed through 
quantification of the AG4 and TF-594 
signals (Figs 4B and C respectively) in 
which the AG4 signal was reduced to 
41.6% and TF-594 increased by 81.6%  
IROORZLQJ 0ȕ&'-treatment. These data 
reveal an important cell biological 
phenomenon whereby endosomal K+ 
accumulation is dependent on cholesterol 
within endosomal membranes.  
 To further dissect the relationship 
between endosomal K+ and cholesterol we 
µprimed¶ BUNV virions for fusion by 
incubation with K+ prior to their addition to 
cells depleted of cholesterol. K+ priming 
leads to the activation of the viral fusion 
machinery, such that endosomal K+ 
concentrations no longer influence fusion. 
,I WKH LQKLELWRU\ HIIHFW RI 0ȕ&' RQ
infection is a consequence of altering K+ 
within endosomes, then this K+ priming 
VKRXOG DOOHYLDWH WKH HIIHFW RI 0ȕ&' RQ
virus growth. 
 To test this, cells were treated with 
0ȕ&' IRU  KRXU, whilst virions were 
incubated for 2 hours in mildly acidic 
buffers (pH 6.35), with or without exposure 
to high K+. Following incubation, the 
virions were incubated in normal media 
prior to infection (MOI 0.1) so as to dilute 
out the high K+, and return the pH to 
neutral. Infection was allowed to proceed 
for 18 hrs, to allow the initiation of BUNV-
N production according to our previous 
time-course analysis (17). 
The data in Fig 4D show a 
significant increase in BUNV-N production 
when virions are treated in the presence of 
K+ (+), compared to without K+ (-), 
consistent with our previous studies 
demonstrating that pH 6.35/K+ primed 
virions undergo an accelerated entry stage 
of their life cycle (16). In cells treated with 
0ȕ&'infection was notably decreased for 
virions incubated without high K+, 
consistent with that shown in Fig 1. 
Critically however, when virions were 
treated with pH 6.35/high K+, infection in 
WKH SUHVHQFH RI 0ȕ&'-treatment was 
almost equivalent to no-drug cells, 
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suggesting that K+ primed virions 
RYHUFRPHWKHHIIHFWVRI0ȕ&'DQGWKXVdo 
not require cellular cholesterol (Fig. 4D & 
E). The activity of 0ȕ&' in these assays 
was further confirmed through its known 
ability to inhibit EGF uptake (Fig. 4F). 
Taken together, these data imply that the 
major effects of cholesterol depletion on 
BUNV are mediated through its effects on 
cellular endosomal [K+].  
 
 
Cellular cholesterol is also required for 
HAZV infection through its effects on 
endosomal K+ 
BUNV and HAZV are both 
members of the Bunyavirales order, and 
their entry pathways have similarities 
[6,33,34]. We therefore examined whether 
HAZV, like BUNV, requires cellular 
cholesterol during entry, thus establishing 
the possibility of an order-wide 
dependence. 
 We first explored if cholesterol 
depletion similarly impedes HAZV 
infection using experimental conditions 
identical to those described for BUNV. 
Cells were infected with HAZV (MOI 0.2) 
and the reliance on cholesterol examined 
through the detection of HAZV-N by either 
immunofluorescence or western blotting. 
)ROORZLQJFHOOXODU0ȕ&'WUHDWPHQWDFOHDU
decrease in the number of HAZV-infected 
cells was observed (Fig 5A) which when 
quantified revealed a 59.47% decrease 
compared to no-drug controls (Fig 5B, 
black bars). These data were supported by 
western blot analysis (Fig 5C) in which 
HAZV-N expression decreased in a 
concentration dependent manner with 2 
P00ȕ&'WUHDWPHQWUHGXFLQJHAZV-N to 
78.58% (Fig 5D). The cholesterol 
requirement of HAZV was further 
confirmed via treatment of cells with PF-
429242 (Fig 5E and F) and U-18666A (Fig 
5G and H). Western blot analysis of 
HAZV-N in PF-429242 treated cells (Fig 
5E) revealed a concentration dependent 
inhibition, which when quantitated showed 
a decrease in infection to 51.72%, 67.12%  
and 98.66% in cells treated with 20, 10 and 
5 ȝ0 3)-429242 respectively (Fig 5F, 
black bars). When experiments were 
performed using U18666A, a concentration 
dependent inhibition of HAZV was also 
observed (Fig 5G), revealing a reduction of 
HAZV infection to 22.98% in cells treated 
with 10 ȝ08$with 5 ȝ0 
and to 47.52% with 2.5 ȝ0 (Fig 5H). MTS 
data (grey bars in all panels) demonstrated 
no cellular toxicity in response to any drug 
treatment. We further sought to explore the 
effect of the cholesterol requirement of 
HAZV by using the clinically approved 
compound simvastatin. Western blot 
analysis of HAZV-N in simvastatin-treated 
cells revealed a concentration-dependent 
inhibition of infection (Fig 5I), which when 
quantified yielded a reduction of HAZV-N 
to 44.77%, 59.99%, 67.64% and 85.20% in 
cells treated with 50, 35, 20 and 10PM 
respectively. 
We have previously shown that high [K+] 
activates the fusion machinery of HAZV at 
pH 7.35 [15]. As such, we sought to explore 
wKHWKHU WKH HIIHFW RI +$=9 µSULPLQJ¶
could also de-sensitise virions to the effects 
of cholesterol depletion. To test this, cells 
ZHUHWUHDWHGZLWK0ȕ&'IRURQHKRXU and 
HAZV virions were incubated for 2 hours 
in buffers of pH 7.35 with or without high 
[K+]. Virions were subsequently added to 
normal media to dilute high the [K+] and 
added to cells for 18 hours (MOI 0.1). 
Fig 5L shows a significant increase 
in HAZV-N production when primed with 
high [K+] (+) at pH 7.35, compared to 
unprimed virions at pH 7.35 alone (-), 
suggesting that these conditions expedite an 
early stage of the HAZV life cycle in a 
manner comparable to the effect seen in 
BUNV. Similarly to the effects shown in 
Fig 4A-D, 0ȕ&'-treatment significantly 
inhibited HAZV infection when treated 
without high K+ (-). Importantly, when 
HAZV virions were primed with high K+ 
(+) LQIHFWLRQ RI 0ȕ&'-treated cells 
occurred at levels similar to that of no-drug 
cells, suggesting that HAZV is also able to 
overcome the effects RI 0ȕ&' RQ FHOOV
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when primed with high K+. These data 
reinforce the dependence of HAZV on the 
correct endosomal environment for entry, 
and further suggest that cholesterol 
mediates the formation of K+-rich 
endosomes required for the escape of 
BUNV and HAZV virions. 
 
  
DISCUSSION 
 The composition of biological 
membranes is crucial to the physiological 
function of cells, and cholesterol is an 
important regulator of membrane integrity 
and fluidity (18). As such, aberrations in 
cholesterol homeostasis can disrupt cellular 
uptake mechanisms, including uptake of 
both beneficial and detrimental cargos.  
 By performing pharmacological 
manipulation of cellular cholesterol content 
YLD H[WUDFWLRQ ZLWK 0ȕCD, or interfering 
with sterol synthesis/trafficking pathways 
(inhibition using PF-429242, U-18666A 
and simvastatin), we showed that both 
BUNV and HAZV are sensitive to changes 
in cellular cholesterol content (Fig 1 and 
Fig 5). As such, the peribunyaviruses and 
nairoviruses can be added to the list of virus 
families that are known to require 
cholesterol to establish an infection (37). 
This list includes many enveloped viruses, 
for which cholesterol depletion has been 
reported to disrupt specific stages of the 
virus life cycle. For example, in the case of 
the togavirus SFV and influenza virus, 
cholesterol has a role in membrane fusion 
(19, 35), whereas in contrast the 
polyomavirus SV40 requires cholesterol as 
it enters cells through caveolae-mediated 
endocytosis (originating from cholesterol 
rich lipid rafts) (38, 39). In the case of the 
flavivirus West Nile virus (WNV) cellular 
cholesterol depletion restricts virus 
replication as a result of the disruption of 
cholesterol-rich microdomains (40). The 
flavivirus hepatitis C virus is also sensitive 
to changes in cellular cholesterol 
accumulation (resulting from U-18666A 
treatment) but the affected stage of the 
replication cycle is late, namely virus 
assembly and egress (31). In this study, 
time of addition experiments and the 
progression of labelled viruses showed that 
the effect of cholesterol depletion on 
BUNV was not at the initial stage of cell 
penetration, but occurred during the time 
period when the virus escapes from the 
endocytic pathway. Furthermore, we 
showed that cholesterol depletion reduced 
K+ accumulation in the endocytic network, 
leading us to question whether the role of 
cholesterol in BUNV entry was linked to 
endosomal K+ homeostasis, a factor we 
have shown to be critical for BUNV and 
HAZV entry (17, 36, 41). 
However, a competing possibility 
was that cholesterol depletion influences 
membrane fluidity and thus obstructed 
fusion between viral and endosomal 
envelopes. To rule out this latter possibility, 
ZHµSULPHG¶%819E\DGGLWLRQRI.+, thus 
circumventing the need for elevated K+ in 
endosomes. Our observation that the entry 
of primed virus was no longer hindered by 
cholesterol depletion indicated that 
restriction of virus growth was not related 
to membrane fluidity. Instead, we suggest 
our findings are consistent with cholesterol 
disrupting K+ accumulation in endosomes, 
which consequently hinders activation of 
the fusion machinery in the appropriate 
endosomal compartment. One possible 
mechanism by which this may occur is that 
the cellular channels responsible for 
endosomal K+ accumulation require 
cholesterol containing membrane sub-
domains either for their full activity, or 
alternatively for incorporation into their 
native endosomal targets. As such, channels 
residing in endosomal membranes depleted 
of cholesterol may show impaired activity, 
thus slowing or preventing K+ influx into 
endosomes, inhibiting the K+ cue for 
endosomal escape (Fig. 6). Interestingly, 
cholesterol can influence K+ channel 
functionality and has been found in 
association with the two-pore domain K+ 
(K2p) channels, acting as a linker between 
the central cavities of these channels and 
the plasma membrane core (42). Work is in 
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progress in our laboratory to identify the 
specific cellular K+ channel(s) involved in 
endosomal K+ accumulation, and current 
evidence derived from an extensive 
pharmacological screen of blocking agents 
indicates it is a member of the above 
mentioned K2P channel family. Once this 
information is confirmed, we will be able to 
further our current findings by examining 
how cholesterol influences the distribution 
or activity of the K2P channel involved. 
 While our findings reported here 
represent the first identification of a 
cholesterol requirement for infection by 
members of either the Peribunyaviridae or 
Nairoviridae families, a previous study 
revealed that replication of Andes virus 
(ANDV), a pathogenic hantavirus of the 
Bunyavirales order was blocked when the 
major cellular sterol pathway was 
dysregulated either by genetic or 
pharmacological means(20). Critical genes 
involved included SREBP2, S1P, S2P and 
SCAP, and gene ablation or knock-down 
studies using a non-replicating recombinant 
vesicular stomatitis virus pseudotyped with 
ANDV-G revealed a block in an 
undetermined stage of entry. The sterol 
pathway requirement was extended to 
infectious ANDV, and treatment of cells 
with a statin (mevastatin), a clinically-
approved cholesterol lowering drug, 
reduced infection by over 10-fold. Despite 
the fundamental differences between 
hantaviruses, peribunyaviruses and 
nairoviruses that has led to their taxonomic 
separation, the possibility that infection and 
disease caused by highly pathogenic 
bunyaviruses may be treated or prevented 
by treatment with existing drugs is an 
exciting prospect. 
 
 
  
  
9 
 
EXPERIMENTAL PROCEDURES 
Cells and Virus 
 A549 (lung epithelial carcinoma) 
and SW13 (human adrenal carcinoma) cells 
were obtained from the European 
Collection of Cell Cultures (ECACC). 
A549 and SW13 cells were maintained in a 
humidified incubator at 37°C with 5% CO2, 
DQG FXOWXUHG LQ 'XOEHFFR¶V PRGLILHG
HDJOH¶V PHGLXP '0(0 6LJPD-Aldrich) 
with 10% foetal calf serum (FCS), 100 
8POSHQLFLOOLQDQGȝJPOVWUHSWRP\FLQ
(1% pen/strep). For the experiments 
detailed below, unless otherwise specified, 
A549 and SW13 cells were seeded into 6 
well (~0.3x106 cells/well) or 12 well plates 
(~0.1x106 cells/well) and incubated at 37ºC 
for 24 hrs to allow cell adherence prior to 
each experiment. 
 Wild-type BUNV and HAZV 
stocks were made from clarified baby 
hamster kidney (BHK) cell supernatants 
and stored at -80°C, suspended in DMEM 
and 10% FCS. Titres were estimated by 
plaque assay, yielding ~3.5x106 PFU/ml 
and ~7x106 PFU/ml for BUNV and HAZV 
respectively. 
 SYTO82/DiD-labelled BUNV was 
produced as described previously (16), 
whereby the three RNA segments are 
labelled using a SYTO82 nucleic acid stain, 
the viral lipid envelope labelled using a 
DiD-vybrant lipid label and the virions 
purified. Recombinant BUNV in which 
eGFP is fused to the N terminus of 
truncated Gc (BUNV-GFP) was kindly 
provided by Xiaohong Shi from CVR 
Glasgow). 
 
Virus Infection & Drug Treatment Assays 
TCEP Assays 
 Stock solutions of Tris (2-
carboxyethyl) phosphine hydrochloride 
(TCEP, Sigma-Aldrich) were made to 1 M 
in deionised sterile water and frozen at -
20°C. These stocks were diluted to 10 mM 
in Opti-MEM reduced serum media 
(Gibco) prior to each experiment. A549 
cells were infected with BUNV or HAZV 
(MOI = 0.2) (T=0) and incubated at 37°C. 
Cells were washed in phosphate-buffered 
saline (PBS) and 10 mM TCEP added for 5 
minutes at the time points indicated; 0.5-
120 minutes post infection. Cells were 
washed in PBS following TCEP treatments 
and incubated at 37°C in DMEM. Cells 
were lysed or fixed at 24 hpi and 
immunoblotted or immunostained (see 
below) for IncuCyte Zoom® analysis of 
viral N protein. 
 
0ȕ&'(QWU\$VVD\V 
 A549 cells were PBS washed and 
pre-infection treated with 2 mM, 1 mM or 
0.5 mM methyl-EHWDF\FORGH[WULQ0ȕ&'
Sigma-Aldrich) for 45 minutes at 37°C. 
Cells were PBS washed to remove drug and 
infected with BUNV or HAZV (MOI = 0.2) 
for 2 hours to allow virus entry. Media and 
non-internalised virions were removed via 
1xPBS wash and 3x 0.5% trypsin washes (2 
hpi) and replaced with complete DMEM. 
Infection was allowed to proceed until 24 
hpi, followed by lysis or fixation for 
western blot or IncuCyte Zoom® analysis. 
 
Simvastatin, PF-429242 and U18666A 
Entry Assays 
 A549 cells were treated with 
Simvastatin (Sigma-Aldrich; 10, 20, 25 or 
ȝ0 PF-429242 (Sigma-Aldrich; 20, 10 
RUȝ0RU8-18666A (Abcam; 10, 5 or 2.5 
ȝ0IRUKRXUV&HOOVZHUHVXEVHTXHQWO\
infected with BUNV or HAZV (MOI = 0.2) 
for 24 hours with the drug(s) maintained 
throughout. At 24 hpi cells were lysed for 
analysis. 
 
SYTO82/DiD-labelled BUNV infection of 
0ȕ&'-treated cells 
 A549 cells were seeded onto 1 
cm2 glass-bottom 8-ZHOO ȝ-slides (Ibidi). 
Cells were treated with 2 mM 0ȕ&'IRU
minutes, after which drug was washed off 
with PBS and cells infected with 
SYTO82/DiD-labelled BUNV (MOI = ~8) 
for 30 minutes at 4°C, to allow virus 
binding. This was followed by warming to 
37°C, to allow synchronised entry, and 
incubation for 8 hours. 30 minutes prior to 
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imaging cells were stained with 
CytoPainter organelle stain (Abcam) for 30 
minutes. Cells were washed with PBS and 
live imaged by confocal microscopy in 
fresh DMEM. 
  
0ȕ&'DQG1+4Cl Time of Addition Assays 
 A549 cells (x8 wells total) were 
infected with BUNV (MOI (0.1) (t=0), with 
one well pre-treated (0 hpi time point) with 
0ȕ&'  P0 RU DPPRQLXP FKORULGH
(NH4Cl, 10 mM, Sigma-Aldrich) for 45 
minutes prior to infection. At 1 hpi non-
internalised virus was washed off and 
media or drug added to the corresponding 
ZHOOV0ȕ&'RU1+4Cl was added to cells 
at the time points indicated; 1-10 hpi. 
Infection was allowed to proceed until 24 
hpi, lysed and BUNV infection assessed by 
western blot detection of BUNV-N. 
 
Viral Envelope Cholesterol Depletion 
 HAZV or BUNV-GFP virions were 
WUHDWHGZLWK0ȕ&'P0IRUPLQXWHV
at 37°C. 0ȕ&'ZDVGLOXWHGLQWRFRPSOHWH
media and A549 cells were subsequently 
infected with treated virions (MOI 0.5) for 
24 hours. Cells were fixed or lysed for the 
detection of HAZV-N/GFP by 
immunofluorescent staining (IncuCyte 
Zoom®) or HAZV-N/BUNV-N by western 
blotting. 
 
9LVXDOLVDWLRQ RI 0ȕ&'-treated BUNV by 
negative staining 
 BUNV was collected from BHK-21 
supernatants, purified through 30% sucrose 
and re-suspended overnight in 0.1x 
PBS. Purified BUNV virions (1.5x109 
PFU/ml) were treated with 2 P0 0ȕ&' 
for 90 minutes at 37°C. Preparations were 
added to glow-discharged carbon-coated 
grids and allowed to stand for 1 minute. 
Grids were washed 3x with dH20 and 
stained for 1 minute with 1% aqueous 
uranyl acetate. Preparations were allowed 
to dry and imaged using a FEI Tecnai T12 
electron microscope at 120 kV. Images 
were collected at a nominal defocus 
between -1 and -5 ȝP using a Gatan 
Ultrascan 4000 CCD camera. 
 
BUNV/HAZV Priming Recovery Assays 
 BUNV virions (12 ȝO 02, 
were diluted 1:11 in buffers mimicking the 
change in endosomal pH (pH 7.35 or 6.35) 
and K+ concentration (0 or 140 mM KCl), 
and incubated for 2 hours at 37°C). Buffers 
were diluted out into 2 ml fresh DMEM 
prior to addition onto cells and added 
LPPHGLDWHO\WR$FHOOV)RUWKH0ȕ&' 
(2 mM) drug-treated samples, cells were 
treated for 1 hour prior to infection (during 
virus priming) or left untreated, and drug 
was removed from wells prior to infection. 
Cells were incubated until 18 hpi and lysed. 
+$=9 YLULRQV ȝO 02,  ZHUH
diluted 1:11 in buffers mimicking early 
endosomal compartments (pH 7.35) plus or 
minus 140 mM KCl, and incubated as 
above. A549 cells were treated with 2 mM 
0ȕ&' IRU  KRXU GXULQJ SULPLQJ RU OHIW
untreated so as to mirror the conditions used 
in BUNV assays, and infected with 
HAZV/buffer in 2ml fresh DMEM for 18 
hours prior to lysis and screening for 
HAZV-N. 
 
pH/ion Buffer Preparation 
 A pH 7.35 buffer was used as a 
control alongside pH 6.35 buffers with a 
high or low K+ concentration, prepared with 
0.2 M Tris (pH 7.35) or 0.3 M Bis-Tris (pH 
6.35). The desired salt concentrations were 
achieved by adding 12 mM NaCl and +/- 
140 mM KCl. On the day of use buffers 
were adjusted to desired temperature and 
pH using 30% HCl. 
 
K+ Uptake Assays 
 A549 cells were treated pre-
infection with 2 mM 0ȕ&'LQ2SWL-MEM 
for 45 minutes at 37°C, or left untreated as 
a control. Cells were simultaneously treated 
with  ȝ0 PHPEUDQH-impermeable 
Asante Potassium Green-4 (AG4) and 2 
µg/ml Alexa Fluor-conjugated Transferrin-
594 for 45 minutes, with 0ȕ&' LQ WKH
media throughout. Cells were washed in 
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PBS and live imaged using the IncuCyte 
Zoom® system. 
 
MTS Cell Viability Assays 
 A549 cells were seeded into 96-well 
tissue culture plates (0.05x106 cells/well) 
and allowed to grow to 70-80% confluency. 
Cells were then treated with the respective 
drugs alongside an untreated and H2O 
treated control for 24 hours, the maximum 
time these drugs were applied for. Cells 
were then screened for viability using 
CellTitre 96® reagent (Promega), 20 µl 
added in serum free media following 
PDQXIDFWXUHU¶V LQVWUXFWLRQV IRU  KRXU
Viability was analysed by reading 
absorbance at 570 nm using a plate reader. 
Results were normalised to the untreated 
control. 
 
Western Blot Analysis 
 At the time points stated cells were 
lysed in Leeds Lysis Buffer (LLB; 25 mM 
glycerol phosphate, 20 mM tris, 150 mM 
NaCl, 1 mM EDTA, 1% triton x 100, 10% 
glycerol, 50 mM NaF, 5 mM Na4O7P2, pH 
7.4) plus protease inhibitor cocktail 
(Thermo Scientific) for 15 minutes at 4°C. 
Lysates were resolved on 12% or 15% 
sodium-dodecyl sulphate (SDS) gels using 
SDS-PAGE. Protein was transferred onto 
polyvinylidene difluoride (PVDF; 
Millipore) membranes using a Bio-Rad 
Trans-blot Turbo. Membranes were 
blocked in 10% milk in TBS-tween for 1 
hour. Proteins were labelled with primary 
antibodies in 5% milk in TBS-tween for 1 
hour at room temperature, then with 
corresponding HRP-conjugated secondary 
antibodies in 5% milk/TBS-tween. 
Labelled proteins were detected by 
enhanced chemiluminescence (ECL) and 
film developed using an Xograph 
processor. Quantification of bands was 
performed using densitometry on ImageJ 
software. 
 BUNV/HAZV was detected using 
BUNV-N/HAZV-N primary antibodies and 
corresponding anti-sheep secondary 
antibodies (1:5000). Anti-GAPDH 
antibodies were used as a loading control 
alongside anti-mouse secondary antibodies 
(1:5000). 
 
Immunofluorescence Staining 
Confocal Analysis 
 Cells were live imaged using an 
inverted LSM-880 confocal microscope 
(Zeiss) on an oil-immersion 63x objective 
lens to image fluorescent labelling - 
SYTO82 (em.max 560 nm), DiDvbt 
(em.max 665 nm), conjugated transferrin-
488 (em.max 518 nm). 
 
IncuCyte Analysis 
 At the indicated time points, cells 
were fixed in 4% paraformaldehyde for 10 
minutes at 4°C. Cells were PBS washed and 
permeabilised with cold 50% 
methanol/acetone for 10 minutes at 4°C. 
Non-specific antibody binding was then 
blocked with 1% bovine serum albumin 
(BSA) in PBS at room temperature for 15 
minutes. Primary anti-BUNV-N or HAZV-
N antibodies were added (1:5000) in 1% 
BSA for 1 hour, followed by 4x PBS 
washes. Corresponding fluorescent Alexa-
Fluor®-594 conjugated anti-sheep 
(Invitrogen-Molecular Probes) secondary 
antibodies (1:500) were added for 2 hours 
in 1% BSA, followed by 4x washes in PBS. 
For K+ uptake assays (2.2.8) cells were live 
imaged, without fixing of staining protocols 
outlined above. 
 Cells were imaged using the 
IncuCyte Zoom® system, widefield images 
of 2.15 mm2 were taken and fluorescently-
labelled infected cells could be identified. 
The mean fluorescence count per well was 
quantified for treated cells using the 
IncuCyte Zoom® 2018 software and results 
normalised to those of untreated cells.
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Figure Legends 
 
Figure 1. BUNV infection is inhibited by cellular cholesterol depletion. (A). A549 cells were 
WUHDWHGZLWK0ȕ&'IRUPLQXWHVDQGLQIHFWHGZLWK%81902,At 24 hpi cells were 
fixed and stained for BUNV-N. Widefield images were taken using an IncuCyte ZOOM® 
(representative images are shown). (B) The percentage of BUNV infected cells was quantified 
using IncuCyte Zoom® software and normalised to no-drug cells (black bars) (*p<0.05, error 
bars representative of ±SD, n=3). Cell viability was assessed by MTS assays. Values were 
normalised to no-drug cells (grey bars). (C) Entry assays were performed as in (A), cell lysates 
were resolved via SDS-PAGE, and BUNV-N expression was assessed by western blot analysis. 
GAPDH was probed as a loading control. (D) Densitometry analysis of (C). Band densities 
were normalised to no-drug BUNV infected cells (black bars). MTS cell viability data is also 
shown (grey bars). (E) BUNV entry assays were performed in the presence of PF-429242. Cells 
were treated with 5-ȝ03)-429242 for 24 hours and infected with BUNV (MOI 0.2) for a 
further 24 hrs. Cells were lysed, and lysates were resolved via SDS-PAGE and screened for 
BUNV-N and GAPDH. (F) Densitometry analysis of (E). (G) Entry assays performed as in (E) 
with U-18666A at 2.5-ȝ0(H) Densitometry analysis of BUNV-N expression following U-
18666A treatment. (I) Entry assays as in (E) with 10-50 ȝ06LPYDVWDWLQ -'HQVLWRPHWU\
analysis of (I) as in (D). 
 
Figure 2. BUNV envelope cholesterol is also required for virus infection. (A) Schematic of 
BUNV envelope cholesterol extraction. GFP-BUNV virions were treated with MßCD for 90 
minutes and the drug/virus was diluted in DMEM and added to A549 cells for 24 hours (MOI 
0.5). (B) Cells were lysed and BUNV-N expression was assessed by western blot analysis. (C) 
Blots were quantified by densitometry analysis and normalised to no drug controls (*p<0.05, 
error bars ± SD, n=3) (D) Virions were treated as in (A) and GFP expression, as a marker of 
BUNV infection, was assessed by IncuCyte analysis. Representative widefield images are 
shown. (E) Percentage of cells infected by MßCD-treated virions were measured using 
IncuCyte ZOOM® software (*p<0.05; error bars ±SD, n=3). (F) Purified BUNV virions were 
treated with 2 P00ȕ&'IRUPLQXWHVDW&7Ueated and untreated (no-drug) virions were 
loaded onto carbon-coated grids and negatively-stained with 1% uranyl acetate. Images were 
taken at 120 kV on a Tecnai T12 electron microscope. 
 
Figure 30ȕ&'LQKLELWV%819DWDQHDUO\SRVW-penetration stage of infection. (A) A549 cells 
were infected with BUNV (MOI 0.1) (t=0). NH4Cl was added at the indicated time points and 
screened for BUNV-N expression at 24 hpi by western blot as in Fig.1. (B) Cells were infected 
DQGWUHDWHGZLWK0ȕ&'DVLQ(A). (C). Densitometry analysis of NH4&ODQG0ȕ&'WLPHFRXUVHV
(A) and (B) (grey and black bars respectively). Band densities were normalised to no-drug 
infected cells (*p<0.05, NS = non-significant, error bars ±SD, n=3). BUNV internalisation 
  
13 
 
takes up to 40 minutes. (D) BUNV virions were added to A549 cells (MOI 0.2) (t=0), which 
were treated with the cell impermeable reducing agent Tris (2-carboxyethyl) phosphine 
hydrochloride (TCEP) for 5 minutes at the indicated post-infection time points (20-120 
minutes). Cells were fixed at 24 hpi, stained for BUNV-N and widefield images were taken 
using the IncuCyte ZOOM®. (E) The percentage of infected cells was quantified using 
IncuCyte Zoom® software. Values are normalised to no-drug infected cells (*p<0.05, NS = 
non-significant, error bars ±SD, n=3). (F) TCEP assays were performed as in (D) and cell 
lysates were harvested and resolved via SDS-PAGE. Lysates were screened for BUNV-N by 
western blot analysis. GAPDH was probed as a loading control. (G) No-drug treated A549 cells 
were infected with SYTO82/DiD-BUNV (MOI ~8) for 8 hours at 37°C. Cytopainter was added 
30 minutes prior to live imaging as a cell marker (scale bar 10 µm. Fluorescent BUNV stained 
with SYTO82 (em.max 560 nm) and DiDvbt (em.max 665 nm) were imaged alongside 
cytopainter (em.max 488 nm). (H) Cells were pre-treated with MßCD for 45 minutes prior to 
infection with SYTO82/DiD-BUNV as in (D). Representative confocal images are shown 
(Scale bar 10 µM). 
 
Figure 40ȕ&'LQKLELWVHQGRVRPDO.+ accumulation, whilst K+ primed BUNV virions can 
overcome cellular cholesterol depletion. (A) Cells were pre-WUHDWHGZLWK0ȕ&'(or no-drug 
control) for 45 minutes and the cell-impermeable K+ dye Asante Potassium Green-4 (AG4) and 
Transferrin-594 (TF-594) were added for 45 minutes at 37°C to permit endosomal uptake. Non-
internalised dyes were removed through PBS washes and live cells were imaged using the 
IncuCyte ZOOM®. Representative widefield images are shown (B) AG4 fluorescence was 
TXDQWLILHG LQ 0ȕ&'-treated cells and normalised to no-drug cells (*p<0.05, NS = non-
significant, error bars ±SD, n=3). (C) Quantitative analysis of TF-594 internalisation in no-
drug YV0ȕ&'-treated cells, analysed as in (B). (D) Cells were pre-WUHDWHGZLWK0ȕ&'IRU1 
hr and BUNV virions were treated with buffers at pH 6.35, with or without 140 mM KCl, for 
2 hours at 37°C. Buffers were diluted into 2 ml of fresh DMEM and immediately added to 
A549 cells. Cells were lysed 18 hpi and immunoblotted for BUNV-N as in Fig 1C. (E) 
Densitometry analysis of (D) as in Fig 1D. (F) Cells were pre-treated with 0.5, 1 or 2 mM 
MßCD for 45 minutes and 2 µg/ml EGF-488 was added to cells for 30 minutes. Widefield 
images were taken using IncuCyte Zoom ® software. 
 
Figure 5. HAZV infection is also inhibited by cellular cholesterol depletion. (A) A549 cells 
ZHUHWUHDWHGZLWK0ȕ&'IRUPLQXWHVDQGLQIHFWHGZLWK+$=902,&HOOVZHUHIL[HG
at 24 hpi and stained for HAZV-N. Widefield images were obtained using the IncuCyte 
ZOOM®. (B) The % of infected cells was quantified using IncuCyte Zoom® software, and 
normalised to no-drug cells (black bars; *p<0.05, error bars ± SD, n=3). Cell viability was 
assessed by MTS assay and normalised to no-drug cells (grey bars). (C) Entry assays were 
performed as in (A), cells were lysed and HAZV-N expression was assessed by western blot 
analysis. GAPDH was used as a control to confirm equal protein loading. (D) Densitometry 
analysis of (C). Band densities were normalised to no-drug cells (black bars, NS = non-
significant, n=3) and compared to MTS cell viability data (grey bars). (E) HAZV entry assays 
in the presence of PF-429242. Cells were pre-treated with 5-ȝ03)-429242 for 24 hours 
and infected with HAZV (MOI 0.2). Cells were lysed at 24 hpi and screened for HAZV-N and 
GAPDH as in (C). (F) Densitometry analysis of (E) as in (D). (G) Entry assays performed as 
in (E) with U-18666A at 2.5-10 ȝ0(H) Densitometry analysis of (G) as in (D). (I) HAZV 
entry assays were performed in the presence of simvastatin. Cells were pre-treated with 10-50 
PM simvastatin for 24 hours and infected with HAZV (MOI 0.2). Cells were lysed and screened 
for HAZV-N and GAPDH as in (C). (J) Densitometry analysis of (I) as in (D). (K) Cells were 
pre-WUHDWHGZLWK0ȕ&'IRURQHKRXU6LPXOWDQHRXVO\+$=9YLULRQVZHUHWUHDWHGZLWKEXIIHUV
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at pH 7.35 with or without 140 mM KCl, for 2 hours at 37°C. The buffers were diluted out into 
2 ml of DMEM and immediately added to A549 cells. Cells were lysed at 18 hpi and 
immunoblotted for HAZV-N as in Fig 1C. (L) Densitometry analysis of (K) as in Fig 1D. (H)  
 
Figure 6. Cholesterol depletion may perturb K+ accumulation in endosomes, preventing virus 
escape. A putative model for the potential role of cholesterol in the accumulation of endosomal 
K+ ions. (A) Endosomal pH and the K+ gradient provides the biochemical cue for virus fusion 
and endosomal escape. This process is likely to be mediated by endosomal K+ channels. (B) 
Cholesterol depletion may inactivate or impair the function of the K+ channel(s) in endosomal 
membranes, slowing or preventing K+ influx into BUNV-containing endosomes. As such, 
BUNV is able to penetrate cells and be internalised into endosomes, but the K+ cue is inhibited, 
impairing endosomal escape and subsequent virus infection.  
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